|
Q2 FY2027
As of Jul 26, 2026
|
Q1 FY2027
As of Apr 26, 2026
|
Q4 FY2026
As of Jan 25, 2026
|
Q3 FY2026
As of Oct 26, 2025
|
Q2 FY2026
As of Jul 27, 2025
|
Q1 FY2026
As of Apr 27, 2025
|
Q4 FY2025
As of Jan 26, 2025
|
Q3 FY2025
As of Oct 27, 2024
|
Q2 FY2025
As of Jul 28, 2024
|
Q1 FY2025
As of Apr 28, 2024
|
Q4 FY2024
As of Jan 28, 2024
|
Q3 FY2024
As of Oct 29, 2023
|
Q2 FY2024
As of Jul 30, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 29, 2023
|
Q3 FY2023
As of Oct 30, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of May 1, 2022
|
Q4 FY2022
As of Jan 30, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, less allowances of $8,328 and $7,976, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid taxes | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $342,356 and $340,331, respectively | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Stockholders' equity : | ||||||||||||||||||||
| Common stock, $0.01 par value, 250,000,000 shares authorized, 104,264,193 issued and 93,324,892 outstanding and 104,264,193 issued and 92,668,555 outstanding, respectively | ||||||||||||||||||||
| Treasury stock, at cost, 10,939,301 shares and 11,595,638 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
